Insmed Inc
F:IM8N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Insmed Inc
F:IM8N
|
US |
|
A
|
Allegheny Technologies Inc
XHAM:ATD
|
US |
|
Rio Tinto Ltd
F:CRA1
|
AU |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
|
U
|
United Insurance Holdings Corp
F:0UI
|
US |
|
Barnes Group Inc
NYSE:B
|
US |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
Air Products and Chemicals Inc
XETRA:AP3
|
US |
|
F
|
Flowserve Corp
F:FWV
|
US |
|
Atlassian Corporation PLC
NASDAQ:TEAM
|
UK |
|
Lagardere SA
LSE:0HB2
|
FR |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
Taylor Devices Inc
NASDAQ:TAYD
|
US |
|
Ameris Bancorp
NASDAQ:ABCB
|
US |
|
Allogene Therapeutics Inc
NASDAQ:ALLO
|
US |
|
R
|
Rush Enterprises Inc
F:RUNA
|
US |
|
T
|
Thomson Reuters Corp
NYSE:TRI
|
CA |
|
R
|
Ramada Investimentos e Industria SA
ELI:RAM
|
PT |
|
B
|
Banco Santander Brasil SA
F:DBSA
|
BR |
|
W
|
Warner Bros Discovery Inc
DUS:J5A
|
US |
Wall St Price Targets
IM8N Price Targets Summary
Insmed Inc
According to Wall Street analysts, the average 1-year price target for IM8N is 229.59 EUR with a low forecast of 191 EUR and a high forecast of 285.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IM8N's stock price target?
Price Target
229.59
EUR
According to Wall Street analysts, the average 1-year price target for IM8N is 229.59 EUR with a low forecast of 191 EUR and a high forecast of 285.51 EUR.
What is the Revenue forecast for Insmed Inc?
Projected CAGR
43%
The compound annual growth rate for Revenue over the next 8 years is 43%.
What is the Gross Profit forecast for Insmed Inc?
Projected CAGR
45%
The compound annual growth rate for Gross Profit over the next 8 years is 45%.
